Literature DB >> 31288034

Characterization of a Novel Bispecific Antibody With Improved Conformational and Chemical Stability.

Prakash Manikwar1, Sri Hari Raju Mulagapati2, Srinath Kasturirangan3, Khashayar Moez4, Godfrey Jonah Rainey3, Brian Lobo4.   

Abstract

Bispecific antibodies containing single-chain variable fragment (scFv) appended to immunoglobulins G offer unique development challenges. Here, we describe the stability of a novel bispecific format, BiS5, where the scFv is tethered to the CH3 domain. BiS5 showed an improved conformational and chemical stability compared with that of BiS4 in which the scFv is appended in the hinge region between the Fab and Fc. By switching the location of the scFv from hinge region to the CH3, there was an improved stabilization of CH2 and scFv domains. Interestingly, no noticeable impact was observed on the conformational stability of CH3 and Fab domains. BiS4 and BiS5 showed different aggregation and fragmentation rates under accelerated temperature stress conditions. BiS4 showed higher fragmentation rates compared with BiS5 likely owing to fragmentation in the linker region on either side of the scFv while BiS5 is more resistant toward fragmentation owing to tethering of scFv to the CH3 domain at its N and C terminus. In conclusion, the location of scFv affects both aggregation and fragmentation kinetics. These insights into the molecular structure and correlations with their physical and chemical stability will help formulation development of these novel bispecific antibodies.
Copyright © 2020 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  aggregation; antibody; bispecific antibody; chromatography; differential scanning calorimetry; formulation; fragmentation; mass spectrometry; scFv; stability

Mesh:

Substances:

Year:  2019        PMID: 31288034     DOI: 10.1016/j.xphs.2019.06.025

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  5 in total

1.  Characterization of a novel bispecific antibody targeting tissue factor-positive tumors with T cell engagement.

Authors:  Zhidi Pan; Jie Chen; Xiaodong Xiao; Yueqing Xie; Hua Jiang; Baohong Zhang; Huili Lu; Yunsheng Yuan; Lei Han; Yuexian Zhou; Huifang Zong; Lei Wang; Rui Sun; Jianwei Zhu
Journal:  Acta Pharm Sin B       Date:  2021-11-03       Impact factor: 14.903

Review 2.  Biology drives the discovery of bispecific antibodies as innovative therapeutics.

Authors:  Siwei Nie; Zhuozhi Wang; Maria Moscoso-Castro; Paul D'Souza; Can Lei; Jianqing Xu; Jijie Gu
Journal:  Antib Ther       Date:  2020-02-17

3.  Common light chain chickens produce human antibodies of high affinity and broad epitope coverage for the engineering of bispecifics.

Authors:  Kathryn H Ching; Kimberley Berg; Kevin Reynolds; Darlene Pedersen; Alba Macias; Yasmina N Abdiche; William D Harriman; Philip A Leighton
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

4.  Detailed Analytical Characterization of a Bispecific IgG1 CrossMab Antibody of the Knob-into-Hole Format Applying Various Stress Conditions Revealed Pronounced Stability.

Authors:  Ingrid Grunert; Katrin Heinrich; Juliane Ernst; Michael Hingar; Alexandre Briguet; Michael Leiss; Manfred Wuhrer; Dietmar Reusch; Patrick Bulau
Journal:  ACS Omega       Date:  2022-01-19

Review 5.  Rapid Multi-Residue Detection Methods for Pesticides and Veterinary Drugs.

Authors:  Min Jia; Zhongbo E; Fei Zhai; Xin Bing
Journal:  Molecules       Date:  2020-08-07       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.